Shana Hardy
Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/Tox FDA/CBERJanuary 25, 2021
11:30 AM Investigational New Drug (IND) Submission Readiness
Take part in a workshop to ensure preparedness for the process for IND applications submission with leaders from academia as well as FDA reviewers.
In Partnership With :
QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com
©2024 IQPC. All rights reserved.
